LMT
32
-12
PEG
67
5
ROK
47
-8
SEE
52
6
ILMN
37
5
FLS
75
2
AKAM
50
7
WU
30
6
SYK
68
4
PAYX
51
4
DVN
18
2
LRCX
45
6
ORLY
60
7
HRL
41
2
ADI
47
2
ALLE
44
7
KR
38
4
MRO
40
-15
HOG
33
4
EXPE
91
3
LMT
32
-12
PEG
67
5
ROK
47
-8
SEE
52
6
ILMN
37
5
FLS
75
2
AKAM
50
7
WU
30
6
SYK
68
4
PAYX
51
4
DVN
18
2
LRCX
45
6
ORLY
60
7
HRL
41
2
ADI
47
2
ALLE
44
7
KR
38
4
MRO
40
-15
HOG
33
4
EXPE
91
3
Financhill
Back

Astellas Pharma Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23

ALPMY
Astellas Pharma

Last Price:
10.13
Seasonality Move:
1.46%

7 Day Trial

ALL ACCESS PASS

$ 7

Access The Stock Grader Trading Tool From "The King Of Quants"

More details here...

Astellas Pharma Price Quote

$10.13

Astellas Pharma Key Stats

Sell
23
Astellas Pharma (ALPMY) is a Sell
Day range:
$9.90 - $10.58
52-week range:
$9.15 - $13.14
Dividend yield:
4.55%
P/E ratio:
154.36
P/S ratio:
1.60
P/B ratio:
1.69%
Volume:
365.2K
Avg. volume:
138.3K
1-year change:
-16.63%
Market cap:
$18.1B
Revenue:
$11.1B
EPS:
$0.06

How Much Does Astellas Pharma Make?

Is Astellas Pharma Growing As A Company?

  • What Is Astellas Pharma's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.11%
  • What Is Astellas Pharma's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Astellas Pharma Stock Price Performance

  • Did Astellas Pharma Stock Go Up Last Month?
    Astellas Pharma share price went down by -13.9% last month
  • Did ALPMY's Share Price Rise Over The Last Year?
    ALPMY share price fell by -16.63% over the past 1 year

What Is Astellas Pharma 52-Week High & Low?

Astellas Pharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Astellas Pharma?

  • How Much Debt Does Astellas Pharma Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Astellas Pharma Have?
    Cash and short term investments quarterly total is $2.4B
  • What Is Astellas Pharma’s Book Value Per Share?
    Book value per share is 5.88

Is Astellas Pharma Cash Flow Positive?

  • What Is ALPMY Cash Flow From Operations?
    Cash flow from operations (TTM) is $1.2B
  • What Is Astellas Pharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $4.3B
  • What Is Astellas Pharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$5.9B

Astellas Pharma Return On Invested Capital

  • Is Management Doing A Good Job?
    ALPMY return on invested capital is 0.66%
  • What Is Astellas Pharma Return On Assets?
    ROA measures how assets are converting to revenues and is 0.47%
  • What Is ALPMY Return On Equity?
    ROE is a measure of profitability and is 0.97%

Astellas Pharma Earnings Date & Stock Price

Astellas Pharma Competitors

Astellas Pharma Dividend Yield

Astellas Pharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0.07% 0%
Revenue: 11.06% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many ALPMY shares are owned by institutional investors?
    1M ALPMY shares are owned by institutional investors
  • How many ALPMY shares are owned by insiders?
    0 ALPMY shares are owned by insiders